Fishawack makes US acquisition
February 4, 2010Medical Communications Nexus Communications, fishawack
Cheshire-based healthcare agency Fishawack Communications has bought US outfit Nexus Communications. The company says this acquisition is part of a …
Oxford Immunotec appoints Frank Vandeputte
February 4, 2010Sales and Marketing Oxford Immunotec, appointment, medical devices, sales and marketing
Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing. He was formerly VP, Europe for …
Eden Biodesign passes into Watson Pharma’s hands
February 4, 2010Manufacturing and Production Eden Biodesign, Watson Pharma, biologicals
UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …
Lancet retracts MMR research conclusions
February 3, 2010Research and Development MMR, Sanofi, vaccines
The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …
Digital Pharma: New EMA website previewed
February 3, 2010Research and Development, Sales and Marketing EMA, branding, digital pharma
The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …
Digital added to PM’s as Langland clean up
February 3, 2010Medical Communications Langland, awards, pm society
Langland swept the board at the PM Society’s Advertising Awards on 29 January with seven wins across 20 award categories. …
FDA to assess Neupogen biosimilar
February 3, 2010Research and Development, Sales and Marketing Hospira, Teva, biosimilars
US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …
Genentech integration hits Roche profits
February 3, 2010Sales and Marketing 2009 financials, Genentech, Roche
Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …
Talking Careers: The brief has changed
February 2, 2010Business Services Talking Point, interim management, rsa, talking careers
Planning for the future is crucial at any time, but particularly when the market has changed and contracted as the …
Brennan maintains support for US reforms
February 2, 2010Sales and Marketing Obama, US healthcare
David Brennan has reiterated the industry’s early support for President Obama’s healthcare plans, but acknowledged the recent election of a …
Parexel sees signs of recovery in Q2 figures
February 2, 2010Research and Development CRO, Parexel
Contract research organisation Parexel International’s second-quarter net profit fell 34% to $3.5 million on restructuring and investment-impairment charges, but still …
Novo buoyed by insulin portfolio
February 2, 2010Sales and Marketing 2009 financials, Novo Nordisk, Victoza
Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …
Job cuts at GlaxoSmithKline and AstraZeneca
February 2, 2010Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline
Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …
Servier fails to overturn NICE osteoporotic guidance
February 2, 2010Sales and Marketing NICE, Servier, osteoporosis
Servier’s challenge to NICE guidance on preventing osteoporotic fractures has proved unsuccessful, with the watchdog’s original decision still standing. This …
ABPI appoints Amanda Stuart head of government affairs
February 2, 2010Sales and Marketing ABPI, appointment, sales and marketing
Amanda Stuart will later this week join the ABPI as its new head of government affairs, with a remit to …
Lilly signs diabetes deal with Alizé Pharma
February 2, 2010Research and Development Alize, diabetes, lilly, type II
Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …
Contract research news in brief
February 2, 2010Research and Development CRO, PRA, Quintiles
Our round-up of contract research news includes alliances for Quintiles and PRA International, a new CRO serving the Eastern European …
Sanofi-Aventis expands consumer health focus in China
February 1, 2010Sales and Marketing China, Minsheng, Sanofi-Aventis, consumer healthcare, em
Sanofi-Aventis has partnered with China’s Minsheng Pharmaceuticals to establish a new consumer healthcare joint venture. Sanofi will take a majority …
Gates’ $10 billion vaccines pledge to cut child mortality
February 1, 2010Research and Development, Sales and Marketing Gates Foundation, developing world, vaccines
Bill and Melinda Gates are to spend $10 billion over the next 10 years to help research, develop and deliver …
Healthy growth for Lilly but Effient doubts raised
February 1, 2010Sales and Marketing 2009 financials, lilly
Lilly’s revenues for the full year rose 7% in 2009, thanks to a growth in sales of Zyprexa, the flagship …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
